Efficacy and Safety of Ruxolitinib in Regularly Transfused Patients with Thalassemia: Results from Single-Arm, Multicenter, Phase 2a Truth Study

Author
Gadbaw, Brian
Karakas, Zeynep
Hollaender, Norbert
Mahuzier, Bruyere
Taher, Ali T.
AYDINOK, YEŞİM
Cassinerio, Elena
Siritanaratkul, Noppadol
Kattamis, Antonis
Maggio, Aurelio
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/118314
https://doi.org/10.1182/blood.v128.22.852.852
Collections